Market cap
Current P/E
50.00x
Forward P/E

About

Health care
Sector
Biotechnology
Industry

Nanobiotix S. A., a clinical-stage biotechnology, focuses on developing product candidates for the treatment of cancer and other unmet medical needs. Its lead product candidate is NBTXR3, a sterile aqueous suspension of crystalline hafnium oxide nanoparticles used for the treatment of soft tissue sarcoma, head and neck cancers, liver cancers, prostate cancer, pancreatic cancer, esophageal cancer, rectal cancer, and non-small cell lung cancer.

Similar securities

Based on sector and market capitalization

Report issue